Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome
Sponsor / Institution: National Heart, Lung, and Blood Institute (NHLBI)
Purpose
To study how nicotinamide riboside affects skeletal muscle after exercise
Study Design
Single group assignment, open label
Dose
1-4 tablets 2x a day
Length of Intervention
12 weeks
Intrinsic Capacity
Locomotion
Status
Completed
Condition or Disease
Cancer
Skin Fibroblasts
Muscle Weakness
Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.